Italia markets open in 26 minutes

BMY Jul 2024 37.500 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,0600+0,0300 (+100,00%)
Alla chiusura: 03:53PM EDT
Schermo intero
Chiusura precedente0,0300
Aperto0,0500
Denaro0,0000
Domanda0,0000
Prezzo d'esercizio37,50
Scadenza2024-07-12
Min-Max giorno0,0500 - 0,0700
Contratto - Min-MaxN/D
Volume24
Open InterestN/D
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri